BioNexus Gene Lab Corp. Gain (Loss) on Termination of Lease
BioNexus Gene Lab Corp. (BGLC) reported Gain (Loss) on Termination of Lease of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-14.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnTerminationOfLease · last filed 2026-04-14
- BioNexus Gene Lab Corp. gain (loss) on termination of lease for the quarter ending 2025-03-31 was $1.38K.
- BioNexus Gene Lab Corp. gain (loss) on termination of lease for fiscal 2025 was $0.00.
- BioNexus Gene Lab Corp. gain (loss) on termination of lease for fiscal 2024 was -$1.38K.
- BioNexus Gene Lab Corp. gain (loss) on termination of lease for fiscal 2023 was $0.00.
| Period end | Gain (Loss) on Termination of Lease 3 month | Gain (Loss) on Termination of Lease 6 month | Gain (Loss) on Termination of Lease 9 month | Gain (Loss) on Termination of Lease 12 month | Gain (Loss) on Termination of Lease 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-04-14 | ||||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 | ||||
| 2025-06-30 | $1.38K 10-Q · filed 2025-08-18 | ||||
| 2025-03-31 | $1.38K 10-Q · filed 2025-05-15 | ||||
| 2024-12-31 | -$1.38K 10-K · filed 2026-04-14 | $1.38K 10-K · filed 2025-04-15 | |||
| 2024-09-30 | $578.00 10-Q · filed 2025-11-14 | ||||
| 2023-12-31 | $0.00 10-K · filed 2025-04-15 | ||||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |